Suchen und filtern

Gefundene Studien

BEMARA Bemarituzumab in patients with FGFR2b-positive advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed at least one prior line of palliative chemotherapy AIO-STO-0224 · In Vorbereitung Studie anzeigen

NeoTRACE A multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer AIO-TRK/YMO-0224 · In Vorbereitung Studie anzeigen

QUINTIS Evaluating fruquintinib in combination with tislelizumab in metastatic colorectal cancer AIO-KRK-0324 · In Vorbereitung Studie anzeigen

neoART A phase Ib/II platform trial evaluating the safety and activity of neoadjuvant trastuzumab-deruxtecan containing combination therapies for HER2+, resectable esophagogastric adenocarcinoma AIO-STO-0124 · In Vorbereitung Studie anzeigen

GUIDANCE Eine multizentrische Phase-II-Studie zur Erhaltungstherapie mit Durvalumab und Olaparib nach standardmäßiger Erstlinienbehandlung (Carboplatin/Cisplatin, Etoposid, Durvalumab) bei HRD-positivem kleinzelligem Lungenkrebs (SCLC) in fortgeschrittenem Stadium AIO-TRK-0124/ass · In Rekrutierung Studie anzeigen

UNITEPANC Using organoids to predict efficacy of adjuvant treatment to improve outcome in resectable pancreatic cancer - Interventional, prospective, multisite, proof-of-concept, single-arm trial, using organoids to predict efficacy of adjuvant treatment in resectable pancreatic cancer - the UNITEPANC trial of the AIO Pancreatic Cancer Group AIO-PAK-0424 · In Vorbereitung Studie anzeigen

CAO/AIO/ARO Alliance Trial for non-resectable pancreatic adenocarcinoma (CONKO-12/NEOLAP-2) Randomized multimodal CAO/ARO/AIO Phase III trial to define the role of radiochemotherapy as part of multi-agent preoperative treatment in borderline and unresectable, localized pancreatic adenocarcinoma (CONKO-12/NEOLAP-2) AIO-PAK-0224/ass · In Vorbereitung Studie anzeigen

ACO/ARO/AIO-23 Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist Anakinra for rectal cancer patients. A phase II trial of the German Rectal Cancer Study Group AIO-KRK-0224/ass · In Vorbereitung Studie anzeigen

ResCPa study Response features, efficacy and safety of CD318-targeted CAR-T cell therapy against pancreatic cancer – ResCPa study AIO-PAK-0124/ass · In Vorbereitung Studie anzeigen

RET-reat Studie - RET Alterationen in soliden Tumoren Nationale, multizentrische, retrospektive Erhebung von Fusionen/Mutationen/Genexpressionsdaten von RET und RET-spezifischen Therapieansätzen AIO-TF/YMO-0124 · In Rekrutierung Studie anzeigen